12 Best Small Cap Pharma Stocks to Buy Now
Emily Field, Head of European Pharma Research at Barclays, spoke on CNBC on February 20 about the performance of obesity medications, the effects of US tariffs, and the dynamics of the pharmaceutical ...
Dynavax Technologies Corp (DVAX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deep Track Capital David Kroin | 17,791,486 | $227,197,276 | +43% | 8.47% |
| 2. | Kynam Capital Derrick Tang | 6,560,835 | $83,781,863 | -22% | 4.95% |
| 3. | Deerfield Management James E. Flynn | 5,193,823 | $66,325,120 | +23991% | 1.25% |
| 4. | 43,500,000 | $57,114,153 | 1.79% | ||
| 5. | 36,369,000 | $47,790,700 | -10% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.00 | 1,000,000 | Director | 8,525,000 | 2020-05-27 | Filing | |
| $3.00 | 16,666 | Director | 30,468 | 2019-08-12 | Filing | |
| $3.00 | 16,667 | Director | 16,667 | 2019-08-12 | Filing | |
| $3.00 | 16,667 | Officer | 118,484 | 2019-08-12 | Filing | |
| $4.04 | 6,000 | Officer | 12,048 | 2017-01-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.00 | 10,000 | Officer | 8,078 | 2025-03-24 | Filing | |
| $13.58 | 14,020 | Officer | 8,078 | 2025-03-18 | Filing | |
| $14.39 | 32,764 | Officer | 22,098 | 2025-03-07 | Filing | |
| $11.93 | 3,615 | 36,905 | 2024-05-31 | Filing | ||
| $12.78 | 13,425 | 0 | 2024-03-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 21,232,309 | $271,136,587 | 0% | |
| 2. | 9,158,084 | $116,948,732 | 0% | |
| 3. | 7,794,524 | $99,536,071 | 0% | |
| 4. | 5,381,380 | $68,720,216 | 1.82% | |
| 5. | 41,058,000 | $54,221,132 | 0.76% |
News See All
Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2024 Earnings Call Transcript
Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2024 Earnings Call Transcript February 20, 2025Dynavax Technologies Corporation reports earnings inline with expectations.
10 Best Small-Cap Stocks Ready To Explode
On October 7, Chuck Royce, founder and Senior Advisor, and Francis Gannon, Co-Chief Investment Officer and Managing Director of Royce Investment, discussed the outperformance of small-cap stocks.
Dynavax Technologies Corporation (NASDAQ:DVAX) Q3 2024 Earnings Call Transcript
Dynavax Technologies Corporation (NASDAQ:DVAX) Q3 2024 Earnings Call Transcript November 7, 2024Dynavax Technologies Corporation beats earnings expectations.
Dynavax Technologies Corporation (NASDAQ:DVAX) Q2 2024 Earnings Call Transcript
Dynavax Technologies Corporation (NASDAQ:DVAX) Q2 2024 Earnings Call Transcript August 6, 2024Dynavax Technologies Corporation beats earnings expectations.
Dynavax Technologies Corporation (NASDAQ:DVAX) Q1 2024 Earnings Call Transcript
Dynavax Technologies Corporation misses on earnings expectations. Reported EPS is $-0.06698 EPS, expectations were $-0.05.
11 Best Low Price Pharma Stocks To Invest In
In this piece, we will take a look at the 13 best low price pharma stocks to invest in.
5 Best Small Cap Pharma Stocks to Invest In
In this piece, we will take a look at the five best small cap pharma stocks to invest in.
Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2023 Earnings Call Transcript
Operator: Good day ladies and gentlemen and welcome to the Dynavax Technologies' Fourth Quarter and Full Year 2023 Financial Results Conference Call. As a reminder, this call is being recorded.
Dynavax Technologies Corporation (NASDAQ:DVAX) Q3 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to Dynavax Technologies' Third Quarter 2023 Financial Results Conference Call. As a reminder, this call is being recorded.